Investors Asset Management of Georgia Inc. GA ADV Sells 816 Shares of CVS Health Co. (NYSE:CVS)

Investors Asset Management of Georgia Inc. GA ADV lowered its stake in CVS Health Co. (NYSE:CVS) by 7.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 9,905 shares of the pharmacy operator’s stock after selling 816 shares during the period. Investors Asset Management of Georgia Inc. GA ADV’s holdings in CVS Health were worth $445,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $25,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health in the third quarter valued at $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health in the 3rd quarter valued at about $32,000. Ridgewood Investments LLC increased its stake in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares during the last quarter. Finally, Stonebridge Financial Group LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $28,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 1.8 %

NYSE CVS opened at $65.20 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $82.21 billion, a P/E ratio of 17.81, a PEG ratio of 0.99 and a beta of 0.61. The business has a fifty day simple moving average of $52.11 and a 200 day simple moving average of $56.18. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, analysts predict that CVS Health Co. will post 5.9 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.08%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s payout ratio is 72.68%.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. UBS Group decreased their target price on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a report on Tuesday, February 11th. Leerink Partnrs raised CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. Wolfe Research upped their price objective on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a report on Tuesday, February 11th. Finally, StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $70.00.

Insiders Place Their Bets

In related news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.